Browsing Posts tagged pixantrone

Lesson Learned: CTIC

No comments

So for those following my posts and the news on Cell Theraputics (CTIC), you’re already aware of what happened.  The FDA’s Oncologic Drugs Advisory Committee unanimously voted against FDA approval of Pixantrone, citing that there was not enough trial data to approve the drug.  Shares had been halted for most of the day on Monday […]

CTIC Update

No comments

Tomorrow, the FDA is scheduled to review Cell Theraputics’ drug Pixantrone (brand name is “Pixuvri”) for the treatment of non-Hodgkin’s lymphoma.  According to the company, patients treated with the drug in a Phase III trial attained a high rate of remissions compared to those patients treated with normal chemotherapy.  Last month, however, the FDA raised […]

Lately, biotechs have been heating up the market, which is why I bring to you another such company: Cell Theraputics, Inc (CTIC).  On Thursday, I had mentioned to Tendo after researching some stocks that CTIC looked to be a good one to invest in, for I saw many similarities to that of GNVC.  Not following […]